In this week’s video, Dr. Brian G.M. Durie advises that patients discuss with their doctors the many aspects of various treatments, including possible toxicities, cost issues, the patient’s overall health, and the patient’s age.

BOTTOM LINE:
Discuss with your doctor if you should choose a two-drug combination versus a three-drug combination.

Have a question? Submit it to AskDrDurie@myeloma.org

IMF Chairman and Co-Founder Brian G.M. Durie, MD welcomes your questions about the latest myeloma treatments, research, controversies and quality of life issues. If you have a question you think might be of interest to the myeloma community, please send to askdrdurie@myeloma.org!

For questions of a specific personal nature, please call the IMF InfoLine coordinators at 800.452.2873 or email them at infoline@myeloma.org

Previous Post
As Federally Funded Medical Research Decreases in the US, Chinese Biotech Surges 500 Percent
Next Post
What Myeloma Patients Should Put in Their Grocery Baskets in 2018

Give Where Most Needed

We use cookies on our website to support technical features that enhance your user experience.

We also use analytics & advertising services. To opt out, click for more information.